MAPK8 and metabolic dysfunction-associated steatohepatitis: Leukocyte Cell Derived Chemotaxin-2 (LECT2), which is elevated in patients with metabolic dysfunction-associated steatohepatitis (MASH), selectively promotes JNK phosphorylation in KCs, leading to liver inflammation [176].